S&P 500 Futures
(0.10%) 5 244.50 points
Dow Jones Futures
(0.12%) 39 584 points
Nasdaq Futures
(0.07%) 18 228 points
Oil
(0.72%) $79.83
Gas
(1.39%) $2.33
Gold
(0.87%) $2 360.70
Silver
(0.99%) $28.65
Platinum
(0.36%) $994.40
USD/EUR
(0.08%) $0.928
USD/NOK
(-0.15%) $10.85
USD/GBP
(0.06%) $0.799
USD/RUB
(-0.77%) $91.83

Actualizaciones en tiempo real para Hypera S.A. [HYPMY]

Bolsa: OTC Sector: Healthcare Industria: Drug Manufacturers—Specialty & Generic
Última actualización9 may 2024 @ 15:37

-0.24% $ 5.92

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 15:37):

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
Volumen de hoy 7 493.00
Volumen promedio 10 261.00
Capitalización de mercado 3.75B
EPS $0.782 ( 2023-09-30 )
Próxima fecha de ganancias ( $0 ) 2024-07-25
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 11.16
ATR14 $0.0290 (0.49%)

Hypera S.A. Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hypera S.A. Finanzas

Annual 2023
Ingresos: $7.91B
Beneficio Bruto: $4.85B (61.30 %)
EPS: $2.61
FY 2023
Ingresos: $7.91B
Beneficio Bruto: $4.85B (61.30 %)
EPS: $2.61
FY 2022
Ingresos: $7.55B
Beneficio Bruto: $4.76B (63.10 %)
EPS: $2.68
FY 2021
Ingresos: $5.94B
Beneficio Bruto: $3.80B (64.05 %)
EPS: $2.11

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.91%) | Divividend Growth Potential Score: 5.91 - Stable (18.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.13 --
Div. Sustainability Score 9.59
Div.Growth Potential Score 5.91
Div. Directional Score 7.75 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.14 %
Dividend Stability
0.49 Below Average
Dividend Score
4.13
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
NEFB Ex Dividend Junior 2023-06-29 Semi-Annually 0 0.00%
CNLPM Ex Dividend Knight 2023-07-07 Quarterly 0 0.00%
TINLF Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
HNFSA Ex Dividend Junior 2023-08-09 Quarterly 0 0.00%
ANPDY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
PGENY Ex Dividend Knight 2023-06-29 Annually 0 0.00%
DBSDY Ex Dividend Knight 2023-08-11 Quarterly 0 0.00%
UUGRY Ex Dividend Junior 2023-06-22 Semi-Annually 0 0.00%
JMSB Ex Dividend Junior 2023-06-26 Annually 0 0.00%
BHWB Ex Dividend Knight 2023-07-27 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2121.5005.778.65[0 - 0.5]
returnOnAssetsTTM0.06041.2007.999.58[0 - 0.3]
returnOnEquityTTM0.1491.5009.4510.00[0.1 - 1]
payoutRatioTTM0.0801-1.0009.20-9.20[0 - 1]
currentRatioTTM1.8070.8005.974.77[1 - 3]
quickRatioTTM1.3140.8006.985.58[0.8 - 2.5]
cashRatioTTM0.6621.5007.4310.00[0.2 - 2]
debtRatioTTM0.378-1.5003.69-5.54[0 - 0.6]
interestCoverageTTM2.281.000-0.266-0.266[3 - 30]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
freeCashFlowPerShareTTM1.8662.009.0710.00[0 - 20]
debtEquityRatioTTM0.910-1.5006.36-9.54[0 - 2.5]
grossProfitMarginTTM0.6151.0003.093.09[0.2 - 0.8]
operatingProfitMarginTTM0.3271.0005.455.45[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1831.000-0.0935-0.0935[0.2 - 2]
assetTurnoverTTM0.2860.800-1.429-1.143[0.5 - 2]
Total Score9.59

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM11.221.0008.970[1 - 100]
returnOnEquityTTM0.1492.509.6510.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.8662.009.3810.00[0 - 30]
dividendYielPercentageTTM0.1771.5005.570[0 - 0.4]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
payoutRatioTTM0.08011.5009.20-9.20[0 - 1]
pegRatioTTM0.03931.500-3.070[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2431.0006.430[0.1 - 0.5]
Total Score5.91

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico